Veterinary oncologists advance cancer drugs for humans and pets
April 15, 2009As more pet owners are choosing to treat their pets' cancers through advanced medicine, veterinarians gain valuable knowledge about the progression and treatment of cancers in humans through pet trials of new drugs. To help organize nationwide trials in tumor-bearing dogs using cancer drugs, the National Cancer Institute has launched the Comparative Oncology Trials Consortium (COTC). Faculty members in the University of Missouri's Scott Endowed Program in Veterinary Oncology participated in COTC's first trial.
"Spontaneous cancers in companion dogs offer a unique, and largely unexplored translational research opportunity for cancer imaging, device and drug development," said Carolyn Henry, professor and director of the Scott Endowed Program in Veterinary Oncology in the MU College of Veterinary Medicine. "Comparative oncology at MU has a long history of advancing cancer treatments in both humans and dogs. In the first COTC trial, we examined a novel drug-delivery method that disrupts blood flow to the tumors but not to the surrounding tissue. The results were effective, and we observed a dramatic decrease in the size of the tumor in one of our patients."
In the study, veterinary oncologists investigated the efficiency of a novel method to deliver the gene for TNF-α to tumor blood vessels. TNF-α is protein made by the body naturally that has anti-tumor effects. Because of the TNF-α protein's toxicity, it cannot be administrated through the bloodstream. The investigators found that the TNF-α gene could be targeted to the tumor using a bacteriophage-based delivery system. Bacteriophage is a virus that can be engineered to target and infect tumor blood vessel cells. This targeted delivery system mitigated the side effects that are seen when the protein is administered systemically. The observations provided insight about the proper dosage of TNF-α to treat both dog and human patients, Henry said.
"Rodent models do not always exhibit the complex relationships between drug exposure and necessary biological changes in tumor tissue that exist in humans," Henry said. "This study provided unique information about the safety of this targeted TNF-α therapy that could not have been demonstrated with rodent animal studies."
The MU Scott Endowed Program in Veterinary Oncology provides many opportunities for translational research. One current project includes collaborating with Valco Instruments, which manufactures various products for the analytical industry, and IsoTherapeutics Group LLC, a company that develops novel diagnostic and therapeutic agents for the treatment of severe diseases, to develop a new technique that improves the administration of radiopharmaceuticals to treat dogs with bone cancer. The new technique shows promise in reducing the negative side effects of the therapy. Canine osteosarcoma, or bone cancer in dogs, is very similar to bone cancer in children.
-
Latest rheumatoid arthritis drugs compared
Apr 17, 2008 |
not rated yet |
0
-
Type of rheumatoid arthritis medication may be associated with increased risk for shingles
Feb 17, 2009 |
not rated yet |
0
-
New cancer treatment targets both tumor cells and blood vessels
Jun 18, 2008 |
not rated yet |
0
-
Multifunctional Gold Nanoparticles Show Promise in Combination Therapy
May 15, 2006 |
not rated yet |
0
-
Cancer cures could work for canines and humans
Jul 12, 2007 |
not rated yet |
0
-
Engineers build first sub-10-nm carbon nanotube transistor
Feb 01, 2012 |
4.9 / 5 (33) |
30
-
Something old, something new: Evolution and the structural divergence of duplicate genes
Jan 31, 2012 |
4.6 / 5 (7) |
1
-
The hidden nanoworld of ice crystals: Revealing the dynamic behavior of quasi-liquid layers
Jan 30, 2012 |
5 / 5 (4) |
1
-
Stock market network reveals investor clustering
Jan 27, 2012 |
3.9 / 5 (23) |
8
-
Of microchemistry and molecules: Electronic microfluidic device synthesizes biocompatible probes
Jan 26, 2012 |
5 / 5 (2) |
0
-
Is Everyday Technology Killing Us?
Feb 08, 2012
-
Exercise and weight loss
Feb 08, 2012
-
Why do we have head aches? Our brains can't feel anything.
Feb 07, 2012
-
"The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
Feb 04, 2012
-
Oncolytic adenovirus
Feb 04, 2012
-
Nutrition label stuffs and diets
Feb 02, 2012
- More from Physics Forums - Medical Sciences
More news stories
Starve a virus, feed a cure? Findings show how some cells protect themselves against HIV
A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online ...
10 hours ago |
5 / 5 (2) |
0
|
Overeating may double risk of memory loss
New research suggests that consuming between 2,100 and 6,000 calories per day may double the risk of memory loss, or mild cognitive impairment (MCI), among people age 70 and older. The study was released today and will be ...
Medicine & Health / Neuroscience
7 hours ago |
5 / 5 (2) |
0
|
Injured boomers beware: Know when to see doctor
(AP) -- It happened to nurse Jane Byron years after an in-line skating fall, business owner Haralee Weintraub while doing "men's" push-ups, and avid cyclist Gene Wilberg while lifting a heavy box.
12 hours ago |
5 / 5 (1) |
0
Declining health-care productivity in England: Who says so?
Reports that the National Health Service in England has been declining in productivity in the last decade appear to have been accepted as fact. However, a Viewpoint published Online First by The Lancet disputes this. The Vi ...
5 hours ago |
not rated yet |
0
FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice
Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...
Medicine & Health / Neuroscience
Feb 09, 2012 |
4.9 / 5 (58) |
17
|
Scientists discover molecular secrets of 2,000-year-old Chinese herbal remedy
For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, ...
New method to examine batteries -- MRI from the inside
There is an ever-increasing need for advanced batteries for portable electronics, such as phones, cameras, and music players, but also to power electric vehicles and to facilitate the distribution and storage of energy derived ...
Google might launch Drive for cloud storage soon
(PhysOrg.com) -- Google's next big move, according to the Wall Street Journal, is a cloud storage service called Drive. Hardly first to the plate, Google is simply catching up to introducing its cloud reposi ...
A mitosis mystery solved: How chromosomes align perfectly in a dividing cell
Although the process of mitotic cell division has been studied intensely for more than 50 years, Whitehead Institute researchers have only now solved the mystery of how cells correctly align their chromosomes during symmetric ...
Lab study raises questions over nano-particle impact
Tests involving chickens have raised questions about the impact on health from engineered nano-particles, the ultra-fine grains commonly used in drugs and processed foods, scientists said on Sunday.
Researchers find extensive RNA editing in human transcriptome
In a new study published online in Nature Biotechnology, researchers from BGI, the world's largest genomics organization, reported the evidence of extensive RNA editing in a human cell line by analysis of RNA-seq data, demons ...